Second, improving cost-effectiveness remains critical
Hoy en da es el frmaco que en faseII induce mayor reduccin de peso, con un 24% (28,5% en mujeres) tras 48semanas con una dosis semanal de 12mg55 (tabla 1), alcanzando importantes beneficios en el control de FRCV y en la reduccin de MASLD56 (fig
The glutathione content of retinal Mller (glial) cells: effect of pathological conditions
Misrepresentation of Efficacy: Claims might argue that manufacturers exaggerated the drugs effectiveness in weight loss or blood sugar control, leading to unrealistic expectations and potential harm
Hypoglycaemia: If you are taking insulin or a sulfonylurea alongside retatrutide, you may be at increased risk of low blood sugar
In most cases, drinking moderate amounts of green tea while on GLP-1 medications is safe